+Vote!
Market Watch (Free subscription) | 10/08/2009
LONDON (MarketWatch) --- Sanofi Pasteur, the vaccines division of the Sanofi-Aventis Group said Thursday that a single dose of influenza A 2009 monovalent vaccines, Panenza or Humenza, administered to children and and adults induced a robust immune response. Both trials are continuing to evaluate the immunogenicity and safety of a second dose of these vaccines. Final data from these...
4Vote!
Business Wire (Free subscription) | 10/26/2009
SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced that its board of directors elected David J. Williams, former chairman and CEO of Sanofi Pasteur, the vaccine business of Sanofi-Aventis Group, and Keith H. Wells, a senior member of the Biologics Consulting Group and former director of...
4Vote!
The Earth Times Online Newspaper (Free subscription) | 10/26/2009
SAN DIEGO - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced that its board of directors elected David J. Williams, former chairman and CEO of Sanofi Pasteur, the vaccine business of Sanofi-Aventis Group, and Keith H. Wells,
